Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (4788 companies, A–Z).
Mercer International reported third-quarter 2026 revenue of $440.7 million and a net loss of $59.2 million, or $0.88 per share, narrower than the $80.8 million loss a year earlier. The company also said it signed restructuring support agreements on November 2, 2026, and expects to commence prepackaged Chapter 11 cases to exchange about $1.1 billion of senior notes for equity, which would substantially change its capital structure and shareholder position.
Restructuring support agreements signed November 2, 2026 with holders of more than 87% of senior notes and a majority of common shares
About $1.1 billion of senior notes to be exchanged for equity, with $400 million of new capital through a fully backstopped rights offering
Q3 2026 Operating EBITDA was negative $2.9 million, compared with negative $28.1 million in Q3 2025; revenue fell about 4% to $440.7 million
Cash and cash equivalents were $71.0 million and total shareholders' equity was a deficit of $158.2 million as of September 30, 2026
Eos Energy reported third-quarter 2026 revenue of $82.7 million, up 171% from a year earlier, and reaffirmed its full-year revenue outlook in the lower half of $300 million to $350 million. The company also reported net income of $125.0 million, driven mainly by non-cash gains on warrants and debt, while its gross loss and adjusted EBITDA loss remained large. It also plans to consolidate its Turtle Creek and Thorn Hill, Pennsylvania, manufacturing sites, with cash restructuring charges of approximately $16 million to $18 million.
Q3 2026 revenue was $82.7 million, up 171% year over year; gross loss widened to $44.2 million from $33.9 million a year earlier.
Net income attributable to shareholders was $125.0 million, mainly from non-cash mark-to-market gains on warrants and debt.
Adjusted EBITDA loss was $63.8 million, narrowing from $71.4 million in the prior quarter but wider than the $52.7 million loss a year earlier.
Board adopted a plan on November 4, 2026 to consolidate Turtle Creek and Thorn Hill; charges of $16 million to $18 million are expected, with actions largely completed by end of June 2027.
Federated Hermes said it is considering operational changes at Federated Hermes Limited, its London-based subsidiary, and has started a consultation process that proposes eliminating or transferring about 200 positions to the United States. The company expects pre-tax restructuring charges of about $15 million, split between $7 million in 2026 and $8 million in 2027, with an approximate $30 million annual pre-tax reduction in compensation and related expenses once completed by the end of 2027.
Proposed restructuring at Federated Hermes Limited would eliminate or transfer about 200 positions, subject to consultation
Expected pre-tax restructuring charges total about $15 million: $7 million in 2026 and $8 million in 2027
Expected annual pre-tax cost reduction of about $30 million, primarily compensation, with completion targeted by end of 2027
Redwood Trust agreed to repurchase $53,125,000 of trust preferred securities from Hildene Capital Management for $45,156,250 plus a $500,000 fee, and the investor agreed to waive the company's REIT maintenance covenant. The Board also approved a plan to revoke the company's REIT election in the first quarter of 2027, adopted a tax benefits preservation plan, and declared a rights dividend, which matter to shareholders because they change the company's tax status, ownership-transfer restrictions, and stock-ownership protections.
Repurchase of $53,125,000 liquidation amount of trust preferred securities at 85% of liquidation amount, or $45,156,250, plus accumulated unpaid distributions, paid in three installments with the last due by February 15, 2027 or the REIT re
Plan to revoke REIT election in the first quarter of 2027 and transition to a C-corporation beginning with the 2027 taxable year
Tax benefits preservation plan declares one right per common share to holders of record on November 16, 2026, exercisable at $20.00 per right
Press release estimates an initial book value benefit of $0.73 to $0.77 per share in the fourth quarter of 2026, and a one-for-five reverse stock split effective January 4, 2027
Vistagen Therapeutics implemented a Board-approved workforce reduction of about 31% on October 26, 2026, keeping staff needed for the U.S. Phase 3 development of fasedienol for social anxiety disorder. The company expects severance and termination costs of about $1.0 million and annual salary and benefit savings of about $3.2 million, and it may incur additional costs not yet contemplated.
Workforce reduced by approximately 31%, implemented October 26, 2026
Estimated severance and termination costs of approximately $1.0 million
Expected annual salary and benefits savings of approximately $3.2 million
Retained capabilities support fasedienol Phase 3 and Phase 2 programs for itruvone and refisolone
LiveWire reported third-quarter 2026 revenue of $7.9 million, up 38% from a year earlier, and a narrower net loss of $18.6 million. The company also disclosed substantial doubt about its ability to continue as a going concern, formed a special restructuring committee, appointed a Chief Restructuring Officer, and withdrew its 2026 operating loss guidance. For shareholders, the improved sales and loss figures are offset by financing risk tied to a December 2027 debt maturity.
Q3 2026 revenue was $7.9 million, up 38% from $5.7 million; units rose 21% to 7,233.
Q3 2026 net loss was $18.6 million, compared with $19.4 million in Q3 2025.
Management determined there is substantial doubt about the company's ability to continue as a going concern, citing a debt maturity in December 2027.
The board formed a special restructuring committee on October 22, 2026, and appointed Roy Gallagher as Chief Restructuring Officer; the 2026 operating loss guidance of $70 million to $80 million was withdrawn.
Dropbox announced a reduction of about 9% of its global workforce to align investments with its top product and growth priorities, with estimated cash costs of $27 million to $33 million and $20 million to $25 million of incremental expense. The company also said its preliminary third quarter 2026 results are expected to be in line with or above its guidance ranges for revenue, constant currency revenue and non-GAAP operating margin, and that Chief Technology Officer Ali Dasdan will step down on November 18, 2026.
Global workforce reduction of approximately 9%, with most cash payments and expense recognized in Q4 2026
Estimated total cash expenditures of $27 million to $33 million; incremental expense of $20 million to $25 million
Preliminary Q3 2026 results expected in line with or above guidance; full results due November 5, 2026
CTO Ali Dasdan steps down effective November 18, 2026, with a $515,000 pro rata bonus and a lump sum payment of about $1.3 million
On October 25, 2026, Maplebear Inc.'s board decided to wind down Caper Cart operations to re-align resources toward the company's strategic priorities. The company expects pre-tax charges of $55 million to $80 million, mostly in the fourth quarter of 2026, with $30 million to $50 million expected to require future cash spending, and the company says actual amounts may differ materially from these estimates.
Pre-tax charges estimated at $55 million to $80 million, primarily in Q4 2026
Charges include $21 million to $36 million for contract terminations, $22 million to $27 million for asset impairments, and $12 million to $17 million for employee termination costs
$30 million to $50 million of the charges expected to result in future cash expenditures
Wind-down expected to be substantially completed by the end of Q2 2027; savings to be reinvested in strategic growth initiatives
On October 20, 2026, eBay announced a restructuring plan that reduces its global workforce by about 9% and estimates GAAP pre-tax charges of $130 million to $150 million, mostly severance. Separately, the company said it expects results for the quarter ended September 30, 2026 to be above its previously provided guidance ranges. Shareholders face near-term charges from the restructuring alongside a stronger-than-guided quarter.
Restructuring plan announced October 20, 2026 reduces the global workforce by about 9%, subject to local law and consultation requirements.
Estimated GAAP pre-tax charges of $130 million to $150 million, substantially all related to severance payments and post-employment benefits.
Majority of the charges expected to be recognized in the fourth quarter of 2026, with the full amount resulting in future cash expenditures.
Expects quarter ended September 30, 2026 results to be above the guidance ranges given in its August 2026 earnings announcement; actions substantially complete by end of Q1 2027.
Fractyl Health is reducing its workforce by about 45% to concentrate resources on its Revita program, and it will stop internal development of its Rejuva gene therapy program while it seeks strategic alternatives for that program. The company expects about $2 million in severance and related charges, mostly in the fourth quarter of 2026, and says its cash should last into the second quarter of 2027, with quarterly cash burn expected to fall about 50% to roughly $8 million by the end of that quarter.
Workforce reduction of approximately 45% of current headcount, expected to be substantially completed by November 2026
Severance and employee termination charges estimated at about $2 million, mostly in Q4 2026; other charges possible but not yet estimated
Jay Caplan retires as President and Chief Product Officer effective October 30, 2026; CEO Harith Rajagopalan appointed President
Cash runway extended into Q2 2027; quarterly operating cash burn expected to fall about 50% to roughly $8 million by end of Q2 2027
Beeline Holdings announced an additional operating expense reduction plan targeting about $250,000 in monthly savings, or $3 million annualized, on top of cuts made earlier in 2026. The company expects about $270,000 in one-time transition expenses through Dec. 1, 2026, after which the full monthly savings are expected to be realized. For shareholders, the plan aims to lower fixed costs and accelerate the path to positive operating cash flow, though the filing gives no Q3 2026 revenue or profit figures.
Targets about $250,000 in monthly savings, or $3 million in annualized operating expense reductions
Incremental to cost reductions implemented earlier in 2026
Expects about $270,000 in one-time transition expenses through Dec. 1, 2026
Company says increased revenues in Q3 2026 were supported by its technology investments and higher-value mortgage products
Daktronics approved a manufacturing network optimization that includes a phased exit from its Ennistymon, Ireland facility and an exit from the highly customized portions of its international transportation business. The company expects $15.8 million in non-recurring pre-tax charges, with about $7.0 million in the current fiscal quarter, and more than $18.0 million in annualized run-rate savings once the actions are fully implemented by mid-fiscal 2028.
Ireland phased exit expected to be substantially complete in the first half of fiscal 2028, with about $13.5 million of cumulative charges
Total charges of $15.8 million, about $7.0 million of which falls in fiscal 2027 Q2
Annualized run-rate savings of more than $18.0 million when fully implemented, expected by mid-fiscal 2028
Separate 8-K Item 8.01 corrects a clerical error in the September 2, 2026 Form 10-Q, which showed fiscal 2027 capital expenditures of $13.2 million; the intended estimate was $23.4 million
Mesa Laboratories approved a restructuring program that eliminates about 40 positions, mainly in its Clinical Genomics division, and exits its Hamburg, Germany facility when its lease expires in February 2027. The company expects a net annualized cost reduction of about $5.0 million after reinvestment, but says Clinical Genomics revenue will be lower as it narrows its focus to pharmacogenomics and oncology.
Estimated total pre-tax charges of $2.6 million to $3.4 million, mainly in the second half of fiscal year 2027
Expected related cash expenditures of $2.9 million to $3.7 million, substantially all over the next 12 months
Savings plan to reduce annualized operating costs by about $9.3 million, with about $4.3 million reinvested
Company will report second quarter fiscal year 2027 results and provide fiscal 2027 guidance on November 9, 2026
Azenta said its board approved a restructuring plan on October 5, 2026, to consolidate its North American laboratory network, cut workforce and close three Multiomics sites in North America. The company estimates $11.0 million to $13.0 million in pre-tax charges, mostly non-cash impairments, with about $7.0 million in future cash spending and about $11.0 million in annualized savings once fully implemented.
Plan approved October 5, 2026, within the Multiomics segment; employee notifications began October 6, 2026
Estimated pre-tax charges of $11.0 million to $13.0 million, including about $9.0 million of asset impairment and about $3.0 million of severance and other restructuring
Estimated future cash expenditures of about $7.0 million; expected annualized cost savings of about $11.0 million
Most charges expected in the fiscal year ending September 30, 2027; actions substantially complete by March 31, 2027
Fair Isaac committed on October 1, 2026 to a workforce reduction that eliminates about 15% of its positions, while reducing management layers, simplifying its operating structure, and integrating AI-driven product development. The company expects aggregate pre-tax charges of about $27.0 million in the fourth quarter of fiscal 2026, mostly severance, and the plan is expected to be substantially complete by the end of the third quarter of fiscal 2027.
About 15% of positions across the company will be eliminated.
Expected pre-tax charges of approximately $27.0 million in Q4 fiscal 2026, mainly employee severance and related costs.
Affected employees began being notified the week of October 5, 2026.
Plan expected to be substantially completed by the end of Q3 fiscal 2027.
HubSpot's board authorized a restructuring plan on October 1, 2026 that eliminates certain roles, affecting about 7% of the workforce; the CEO's employee memo says nearly 660 people will leave. The company estimates $65 million to $75 million in charges, mostly recognized in the fourth quarter of fiscal 2026, and will exclude them from non-GAAP results, while reaffirming its third-quarter and full-year 2026 revenue, non-GAAP operating income and non-GAAP EPS guidance.
Board authorized the plan on October 1, 2026; it affects about 7% of the workforce, and the CEO's memo cites nearly 660 employees.
Estimated charges of $65 million to $75 million, mainly severance, notice period, employee transition and benefits payments.
Majority of charges expected in fourth quarter 2026; role eliminations substantially complete by end of first quarter 2027; substantially all cash payments by June 30, 2027.
Company reaffirmed third-quarter 2026 and fiscal 2026 revenue, non-GAAP operating income and non-GAAP EPS guidance.
Goodyear approved a plan on September 29, 2026 to close its chemical manufacturing facilities in Niagara Falls, New York and Bayport, Texas, affecting about 85 jobs. The company estimates total pre-tax charges of $55 million to $75 million, with about $30 million in cash charges, and expects the plan to improve Americas segment operating income by $15 million to $20 million annually starting in 2027.
Plant closures: Niagara Falls, New York and Bayport, Texas; about 85 job reductions
Estimated pre-tax charges of $55 million to $75 million, of which about $30 million are cash charges
Approximately $35 million of charges expected in Q3 2026 and $15 million in the rest of 2026
Expected annual Americas operating income benefit of $15 million to $20 million beginning in 2027
Workday reiterated its fiscal 2027 third-quarter and full-year guidance from August 27, 2026, except for GAAP operating margin, which it now expects to be roughly 20 to 21 percentage points below non-GAAP margin in the third quarter and about 19 points below for the full year. The company is reducing about 2.5% of its workforce, mainly in Product and Technology, and reducing leased office space, with charges of $65 million to $80 million that shareholders will see in GAAP results.
Reorganizations announced September 29, 2026 include a reduction of about 2.5% of current workforce, mainly in Product and Technology.
Charges of $65 million to $80 million: about $55 million to $70 million in fiscal Q3 and $10 million in fiscal Q4 2027.
Charges include $40 million to $55 million in cash severance and benefit costs, about $10 million in stock-based compensation, and about $15 million in office space impairment.
Employee actions are expected to be substantially complete by Q1 fiscal 2028; office actions by Q4 fiscal 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.